Characterization of Musclin as a new target for treatment of hypertension

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lin, Jia Wei ^a   Tsai, Cheng Chia ^a   Chen, Li Jen ^b   Niu, Ho Shan ^c   Chang, Chen Kuei ^a   Niu, Chiang Shan ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE AGENT; MUSCLE PROTEIN; MUSCLIN; UNCLASSIFIED DRUG; CALCIUM; DEOXYCORTICOSTERONE ACETATE; MUSCLIN PROTEIN, RAT; PHENYLEPHRINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL LINE; CONTROLLED STUDY; DEOXYCORTICOSTERONE-SALT INDUCED HYPERTENSION; HEREDITARY HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RETREATMENT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DISEASE MODEL; GENE EXPRESSION REGULATION; HYPERTENSION; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; CALCIUM; DESOXYCORTICOSTERONE ACETATE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPERTENSION; MALE; MUSCLE PROTEINS; PHENYLEPHRINE; RATS; RATS, WISTAR; SODIUM CHLORIDE;

EID: 84897555207     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/354348     Document Type: Article

References (30)

1. MacMahon S., Blood pressure and the risk of cardiovascular disease. The New England Journal of Medicine 2000 342 1 50 52 2-s2.0-0034610737
2. Hill M. A., Meininger G. A., Davis M. J., Laher I., Therapeutic potential of pharmacologically targeting arteriolar myogenic tone. Trends in Pharmacological Sciences 2009 30 7 363 374 2-s2.0-67649390994 10.1016/j.tips.2009.04.008
3. Yamazaki D., Tabara Y., Kita S., Hanada H., Komazaki S., Naitou D., Mishima A., Nishi M., Yamamura H., Yamamoto S., Kakizawa S., Miyachi H., Yamamoto S., Miyata T., Kawano Y., Kamide K., Ogihara T., Hata A., Umemura S., Soma M., Takahashi N., Imaizumi Y., Miki T., Iwamoto T., Takeshima H., TRIC-A channels in vascular smooth muscle contribute to blood pressure maintenance. Cell Metabolism 2011 14 2 231 241 2-s2.0-79960943895 10.1016/j.cmet.2011.05.011
4. Sonoyama K., Greenstein A., Price A., Khavandi K., Heagerty T., Vascular remodeling: implications for small artery function and target organ damage. Therapeutic Advances in Cardiovascular Disease 2007 1 2 129 137 2-s2.0-59049098499 10.1177/1753944707086358
5. Nishizawa H., Matsuda M., Yamada Y., Kawai K., Suzuki E., Makishima M., Kitamura T., Shimomura I., Musclin, a novel skeletal muscle-derived secretory factor. Journal of Biological Chemistry 2004 279 19 19391 19395 2-s2.0-2442540309 10.1074/jbc.C400066200 (Pubitemid 38623371)
6. Chen W. J., Sui Y. B., Yin X. H., Musclin and insulin resistance. Sheng Li Ke Xue Jin Zhan 2012 43 45 47
7. Liu Y., Huo X., Pang X. F., Zong Z. H., Meng X., Liu G. L., Musclin inhibits insulin activation of Akt/protein kinase B in rat skeletal muscle. Journal of International Medical Research 2008 36 3 496 504 2-s2.0-45149128600 (Pubitemid 351833599)
8. Yasui A., Nishizawa H., Okuno Y., Morita K., Kobayashi H., Kawai K., Matsuda M., Kishida K., Kihara S., Kamei Y., Ogawa Y., Funahashi T., Shimomura I., Foxo1 represses expression of musclin, a skeletal muscle-derived secretory factor. Biochemical and Biophysical Research Communications 2007 364 2 358 365 2-s2.0-35449004069 10.1016/j.bbrc.2007.10.013 (Pubitemid 47633422)
9. Li Y. X., Cheng K. C., Asakawa A., Kato I., Sato Y., Amitani H., Kawamura N., Cheng J. T., Inui A., Role of musclin in the pathogenesis of hypertension in rat. PLoS ONE 2013 8 8 e72004 10.1371/journal.pone.0072004
10. Rodrigues S. F., Granger D. N., Cerebral microvascular inflammation in DOCA salt-induced hypertension: role of angiotensin II and mitochondrial superoxide. Journal of Cerebral Blood Flow and Metabolism 2012 32 2 368 375 2-s2.0-84856444236 10.1038/jcbfm.2011.139
11. Bhatia J., Tabassum F., Sharma A. K., Bharti S., Golechha M., Joshi S., Akhatar M. S., Srivastava A. K., Arya D. S., Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and Oxidative Stress. Cardiovascular Toxicology 2011 11 3 272 279 2-s2.0-80054961170 10.1007/s12012-011-9122-2
12. Seifi B., Kadkhodaee M., Karimian S. M., Zahmatkesh M., Xu J., Soleimani M., Evaluation of renal oxidative stress in the development of doca-salt induced hypertension and its renal damage. Clinical and Experimental Hypertension 2010 32 2 90 97 2-s2.0-77950822403 10.3109/10641960902993111
13. Hoffman W. E., Edelman G., Ripper R., Koenig H. M., Sodium nitroprusside compared with isoflurane-induced hypotension: the effects on brain oxygenation and arteriovenous shunting. Anesthesia and Analgesia 2001 93 1 166 170 2-s2.0-0034950663 (Pubitemid 32601173)
14. Kang B. T., Leoni R. F., Kim D. E., Silva A. C., Phenylephrine-induced hypertension during transient middle cerebral artery occlusion alleviates ischemic brain injury in spontaneously hypertensive rats. Brain Research 2012 1477 83 91 10.1016/j.brainres.2012.08.024
15. Lee P.-Y., Chen W., Liu I.-M., Cheng J.-T., Vasodilatation induced by sinomenine lowers blood pressure in spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology 2007 34 10 979 984 2-s2.0-34547970699 10.1111/j.1440-1681.2007.04668.x (Pubitemid 47274549)
16. Chen Z.-C., Shieh J.-P., Chung H.-H., Hung C.-H., Lin H. J., Cheng J.-T., Activation of peripheral opioid -receptors in blood vessel may lower blood pressure in spontaneously hypertensive rats. Pharmacology 2011 87 5-6 257 264 2-s2.0-79953861171 10.1159/000326084
17. Selye H., Hall C. E., Rowley E. M., Malignant hypertension produced by treatment with desoxycorticosterone acetate and sodium chloride. Canadian Medical Association Journal 1943 49 88 92
18. Brilla C. G., Weber K. T., Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. Journal of Laboratory and Clinical Medicine 1992 120 6 893 901 2-s2.0-0027081410 (Pubitemid 23002899)
19. Brown L., Duce B., Miric G., Sernia C., Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system. Journal of the American Society of Nephrology 1999 10, supplement 11 S143 S148 2-s2.0-0032951864 (Pubitemid 29038179)
20. Loch D., Hoey A., Brown L., Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat. Clinical and Experimental Hypertension 2006 28 5 475 488 2-s2.0-33745845527 10.1080/10641960600798754 (Pubitemid 44034672)
21. McMurphy R. M., Stoll M. R., McCubrey R., Accuracy of an oscillometric blood pressure monitor during phenylephrine-induced hypertension in dogs. American Journal of Veterinary Research 2006 67 9 1541 1545 2-s2.0-33748743900 10.2460/ajvr.67.9.1541 (Pubitemid 44400171)
22. Bia Santana D., Grignola J. C., Armentano R. L., Ginés F. F., Improved pulmonary artery buffering function during phenylephrine-induced pulmonary hypertension. Molecular and Cellular Biochemistry 2003 246 1-2 19 24 2-s2.0-0038417542 10.1023/A:1023491525659 (Pubitemid 36798717)
23. Wang Y., Hou R., Li P., Li J., Yan J., Yin F., Han C., Zhang Y., Gene expression profiles in response to the activation of adrenoceptors in A7R5 aortic smooth muscle cells. Clinical and Experimental Pharmacology and Physiology 2004 31 9 602 607 2-s2.0-4944236366 10.1111/j.1440-1681.2004.04058.x (Pubitemid 39329762)
24. Somlyo A. V., Bond M., Somlyo A. P., Scarpa A., Inositol trisphosphate-induced calcium release and contraction in vascular smooth muscle. Proceedings of the National Academy of Sciences of the United States of America 1985 82 15 5231 5235 2-s2.0-0344367495 (Pubitemid 16242835)
25. Sato K., Ozaki H., Karaki H., Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2. Journal of Pharmacology and Experimental Therapeutics 1988 246 1 294 300 2-s2.0-0023726373
26. Ohtsuki I., Morimoto S., Troponin: regulatory function and disorders. Biochemical and Biophysical Research Communications 2008 369 1 62 73 2-s2.0-40849094355 10.1016/j.bbrc.2007.11.187
27. Metzger J. M., Westfall M. V., Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circulation Research 2004 94 2 146 158 2-s2.0-1042302791 10.1161/01.RES.0000110083.17024.60 (Pubitemid 38197446)
28. Layland J., Solaro R. J., Shah A. M., Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovascular Research 2005 66 1 12 21 2-s2.0-14844344027 10.1016/j.cardiores.2004.12.022 (Pubitemid 40357865)
29. Bootman M. D., Berridge M. J., The elemental principles of calcium signaling. Cell 1995 83 5 675 678 2-s2.0-0028834424 10.1016/0092-8674(95)90179-5
30. Rybalkin S. D., Yan C., Bornfeldt K. E., Beavo J. A., Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circulation Research 2003 93 4 280 291 2-s2.0-0042859823 10.1161/01.RES.0000087541.15600.2B (Pubitemid 37048240)